Literature DB >> 30537209

Salvianolic acid B inhibits the development of diabetic peripheral neuropathy by suppressing autophagy and apoptosis.

Qian-Qian Wang1, Cui Zhai2, Alafate Wahafu3, Yan-Ting Zhu2, Yong-Hui Liu1, Lian-Qing Sun1.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the neuroprotective effects of SalB on high glucose (HG)-induced excessive autophagy and apoptosis in vitro.
METHODS: The proliferation and apoptosis of RSC96 cells were determined using the MTT assay and flow cytometry, respectively. Western blot analysis was performed to examine the expression of autophagy and apoptosis-related proteins. RT-PCR and flow cytometry were manipulated to examine the level of Bcl-2. The signals of autophagy markers were detected using immunofluorescence methods. KEY
FINDINGS: We found that HG significantly reduced RSC96 cell's proliferation and induced apoptosis. What's more, HG increased the level of autophagy and apoptosis-related proteins. However, these effects were reversed by SalB. In addition, we also found that 3-MA decreased the expression of LC3A/B and Beclin1, while the JNK inhibitor SP600125 reduced the levels of phosphorylated JNK, LC3A/B and Beclin1.
CONCLUSIONS: High glucose not only induced apoptosis but also caused autophagic cell death by activating the JNK pathway. These effects prevented by SalB in an opposite manner.
© 2018 Royal Pharmaceutical Society.

Entities:  

Keywords:  Salvianolic acid B; apoptosis; autophagy; diabetic peripheral neuropathy; high glucose

Mesh:

Substances:

Year:  2018        PMID: 30537209     DOI: 10.1111/jphp.13044

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Interplay between exosomes and autophagy machinery in pain management: State of the art.

Authors:  Hamidreza Morteza Bagi; Sajjad Ahmadi; Faezeh Tarighat; Reza Rahbarghazi; Hassan Soleimanpour
Journal:  Neurobiol Pain       Date:  2022-06-09

2.  Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.

Authors:  Lili Zhang; Lin Han; Xinmiao Wang; Yu Wei; Jinghui Zheng; Linhua Zhao; Xiaolin Tong
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

3.  MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARγ/NF-κB.

Authors:  Hanping Qi; Jing Ren; Lina Ba; Chao Song; Qianhui Zhang; Yonggang Cao; Pilong Shi; Bowen Fu; Yongsheng Liu; Hongli Sun
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-14       Impact factor: 8.886

4.  Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice.

Authors:  Ying Bai; Xueli Bao; Qianqian Mu; Xin Fang; Ruyuan Zhu; Chenyue Liu; Fangfang Mo; Dongwei Zhang; Guangjian Jiang; Ping Li; Sihua Gao; Dandan Zhao
Journal:  PeerJ       Date:  2021-02-03       Impact factor: 2.984

Review 5.  Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage.

Authors:  Zhun Xiao; Wei Liu; Yong-Ping Mu; Hua Zhang; Xiao-Ning Wang; Chang-Qing Zhao; Jia-Mei Chen; Ping Liu
Journal:  Front Pharmacol       Date:  2020-11-11       Impact factor: 5.810

6.  Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway.

Authors:  Na Jiang; Jing Zhang; Jian Ping; Lieming Xu
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

7.  Salvianolic acid B combined with bone marrow mesenchymal stem cells piggybacked on HAMA hydrogel re-transplantation improves intervertebral disc degeneration.

Authors:  Jie Hu; Cai Li; Shichang Jin; Yuchen Ye; Yuekun Fang; Panpan Xu; Changchun Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-27

8.  Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice.

Authors:  Yiran Liang; Hong Liu; Yi Fang; Pan Lin; Zhihui Lu; Pan Zhang; Xiaoyan Jiao; Jie Teng; Xiaoqiang Ding; Yan Dai
Journal:  J Cell Mol Med       Date:  2020-12-17       Impact factor: 5.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.